Business Name: |
Oepen Godehard MD |
Contact Person: |
Godehard Oepen |
Address: |
2868 Acton Road, Birmingham, Alabama 35243 |
Phone Number: |
(205) 968-8360 |
Website Address: |
apsy.com |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Langschwager Hans A MD - Birmingham, AL 35243 Stetler William R MD - Birmingham, AL 35243 Saunders AL MD - Birmingham, AL 35243 Uab Health System - Birmingham, AL 35243 Taylor Stephen M MD - Birmingham, AL 35243 Mc Afee Alison W MD - Birmingham, AL 35243 Richesin Renee R MD - Birmingham, AL 35243 Amling Christopher MD - Birmingham, AL 35243 Henderson Ronald E MD - Birmingham, AL 35243 Conry Robert M MD - Birmingham, AL 35243 Keriotis Annabelle A MD - Birmingham, AL 35243 Rayburn Barry MD - Birmingham, AL 35243 Scalise Pierre MD - Birmingham, AL 35243 Mirza Saema MD - Birmingham, AL 35243 Bryant Jr Robert E MD - Birmingham, AL 35243 Jackson Jerry W MD - Birmingham, AL 35243 Godby Kelly N MD - Birmingham, AL 35243 Yang Shih-Hsin E MD - Birmingham, AL 35243 Iverson Kenneth C MD - Birmingham, AL 35243 Dumas Jr Roland F MD - Birmingham, AL 35243 |
The company Oepen Godehard MD provides B2C services in the form of Doctors from its single location in Alabama.
1 to 4 employees work for Oepen Godehard MD, and the business now earns $500.000 to $999.999 per annum.
Oepen Godehard MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Oepen Godehard MD, please call Godehard Oepen with the phone number (205) 968-8360 or visit its single location at 2868 Acton Road in Birmingham, Alabama 35243.
The location of the single location can also be found using the coordinates 33.42956,-86.74065.
Read more details about this business on the webpage apsy.com or follow the company’s social media accounts, on Twitter and on Facebook.